Outcome of pregnancy in patients with primary sclerosing cholangitis. Issue 4 (April 2022)

• Record Type: Journal Article
• Authors: Wronka, Karolina M.; Bik, Emil; Milkiewicz, Piotr
• Is Part Of: Digestive and liver disease. Volume 54:Issue 4(2022)
• Page Start: 509
• Page End: 514
• Publication Date: 2022-04
• Subjects: Liver disease -- Primary sclerosing cholangitis -- Pregnancy -- Ursodeoxycholic acid; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2021.08.015
• Languages: English
• ISSNs: 1590-8658

Abstract

Abstract: Background: Data on the clinical course of primary sclerosing cholangitis (PSC) during pregnancy remain scarce. Herein, we assessed the maternal and fetal outcomes of pregnancy in this condition. Methods: We reviewed 104 consecutive female outpatients with PSC using a structured questionnaire. The outcomes were assessed both before and after the diagnosis of PSC. Results: In total, 62 patients (60%) reported 126 pregnancies. Of these, 25 patients reported 44 pregnancies occurring after the diagnosis of PSC. There were two (5%) pregnancies in progress, and among the completed pregnancies there were 34 (80%) live births, six (14%) miscarriages, one (2%) stillbirth, and one (2%) termination. The median neonatal APGAR score was 10, the median body weight was 3375 g and the median body length was 55 cm. In three pregnancies, there was a flare-up of inflammatory bowel disease. In 45 patients, 82 pregnancies occurred before PSC was diagnosed with comparable maternal and fetal outcomes. Out of 42 pregnancies following PSC diagnosis, in 29 UDCA was continued. There was no difference in the fetal outcomes between the UDCA and non-UDCA groups. Conclusions: Pregnancy in patients with PSC seems to be well tolerated, but should be closely monitored by an obstetrician and an experienced hepatologist.